Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

RPR reports squalene synthase inhibitors

Aug. 16, 1996

Takeda claims benzothiepin derivatives to treat bone disease

Aug. 16, 1996

9-cis-retinoids as heart disease therapy described by American Cyanamid

Aug. 9, 1996

Columbia seeks FDA approval of Crinone

Aug. 9, 1996

Aldose reductase inhibitors disclosed by Nippon Zoki

Aug. 9, 1996

FDA approves phaseI/II trial of VivoRx's BetaRx-P

Aug. 9, 1996

FDA approves expanded date labelling for LeukoNet

Aug. 9, 1996

Amgen and Kirin sign NESP collaboration

Aug. 9, 1996

Yamanouchi reports squalene synthase inhibitors

Aug. 9, 1996

Alfa Wasserman reveals antioxidant hypolipidemic compounds

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...